Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV000696405 | SCV000824966 | likely benign | Charcot-Marie-Tooth disease axonal type 2O | 2023-12-18 | criteria provided, single submitter | clinical testing | |
| Molecular Genetics, |
RCV000696405 | SCV002503682 | uncertain significance | Charcot-Marie-Tooth disease axonal type 2O | 2023-03-30 | criteria provided, single submitter | clinical testing | This sequence change is predicted to replace threonine with methionine at codon 543 of the DYNC1H1 protein, p.(Thr543Met). The threonine residue is moderately conserved (100 vertebrates, UCSC), and is located in a coiled coil region that interacts with DYNC1I2 in the Dynein heavy chain N-terminal region 1. There is a moderate physicochemical difference between threonine and methionine. The DYNC1H1 gene is highly constrained for missense variation (gnomAD v2.1.1). The variant is present in a singleton from the South Asian, East Asian, and other subpopulations in a large population cohort ( rs780247153, 3/251,446 alleles, 0 homozygotes in gnomAD v2.1.1). The variant has been identified in a case where a different pathogenic variant in another gene fully explained the phenotype, and in at least three individuals referred for hereditary neuropathy genetic testing who harboured additional variants of uncertain significance in other dominant Charcot-Marie-Tooth disease genes (Invitae personal communication, Royal Melbourne Hospital). Multiple lines of computational evidence have conflicting predictions for the missense substitution (4/6 algorithms predict deleterious). Based on the classification scheme RMH Modified ACMG Guidelines v1.3.1, this variant is classified as a VARIANT OF UNCERTAIN SIGNIFICANCE. Following criteria are met: PM2_Supporting, PP2. |